INNOVATE CORP Aktie

 

PHOENIX, May 23, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE: VATE), announced today that it will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025 to DBMG's stockholders of record at the close of business on June 2, 2025....

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025 to DBMG's stockholders of record at the close of business on June 2, 2025. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $5 million of the total $5.5 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend....

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), has entered into an amended and restated credit agreement that provides for an $85 million term loan and a $135 million revolving credit facility (the “Credit Facility”), which will be used to fully repay DBMG's existing debt obligations and provide additional working capital capacity. ...

- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year -...

NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET....

- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function -- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 -...

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET....

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the assessment of kidney function in patients with normal or impaired renal function....

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN GRIT METALS CORP. O.N. K9T CA39868L1022 HAYASA METALS INC. O.N. FR2 CA4206341071 XANDER RES INC. 1XI CA9838793052 FORTE BIOSCIENCES INC. 37T US34962G2084 INNOVATE CORP. NEW PST0 US45784J3032 AB/FROM ONWARDS 14.01.2025 15:50 CET...

Voigt, Paul - Vorstand - Tag der Transaktion: 2024-11-19...

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has achieved several impressive milestones during 2024. The growing momentum of the brand coupled with recent key partnerships has positioned the company for substantial growth across the aesthetics and wellness sectors....

- Infrastructure: DBM Global third quarter revenue of $232.8 million -- Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter -- Spectrum: Broadcasting's delivered another quarter of strong growth driven by network launches -...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

Instrument ID [20541136] (PST0 - US45784J3032) suspended...

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL INNOVATE CORP. NEW PST0 US45784J3032 BAW/UFN...

Das Instrument PST0 US45784J3032 INNOVATE CORP. NEW EQUITY hat seinen ersten Handelstag am 09.08.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument PST0 US45784J3032 INNOVATE CORP. NEW EQUITY has its first trading date on 09.08.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA36468M1005 Gamelancer Media Corp. 08.08.2024 CA92540L1076 Vertiqal Studios Corp. 09.08.2024 Tausch 1:1 US45784J1051 Innovate Corp. 08.08.2024 US45784J3032 Innovate Corp. 09.08.2024 Tausch 10:1...